IMPAIRED GLUCOSE TOLERANCE (PREDIABETES)
Clinical trials for IMPAIRED GLUCOSE TOLERANCE (PREDIABETES) explained in plain language.
Never miss a new study
Get alerted when new IMPAIRED GLUCOSE TOLERANCE (PREDIABETES) trials appear
Sign up with your email to follow new studies for IMPAIRED GLUCOSE TOLERANCE (PREDIABETES), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly shot aims to turn back the clock on prediabetes
Disease control Not yet recruitingThis study tests whether a once-weekly injectable drug called mazdutide can help adults with prediabetes achieve normal blood sugar levels. About 150 participants will receive either a low dose, a higher dose, or a placebo for 24 weeks, along with diet and exercise advice. The ma…
Matched conditions: IMPAIRED GLUCOSE TOLERANCE (PREDIABETES)
Phase: PHASE4 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New supplement aims to tame blood sugar spikes in prediabetes
Disease control Not yet recruitingThis study tests a supplement called GlycoDual in 90 adults with prediabetes (higher-than-normal blood sugar). For 90 days, half will take GlycoDual and half a placebo. Researchers will check if GlycoDual lowers fasting and after-meal blood sugar and improves how the body uses in…
Matched conditions: IMPAIRED GLUCOSE TOLERANCE (PREDIABETES)
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Scientists probe growth Hormone's role in prediabetes to unlock diabetes clues
Knowledge-focused Not yet recruitingThis study looks at how beta-cells (which make insulin) respond to growth hormone in people with prediabetes. Researchers will measure insulin release in 10 adults with impaired fasting glucose or impaired glucose tolerance. The goal is to better understand what raises the risk o…
Matched conditions: IMPAIRED GLUCOSE TOLERANCE (PREDIABETES)
Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study tracks 300 people at risk for type 1 diabetes over 10 years
Knowledge-focused Not yet recruitingThe SIRENA study will follow 300 children and adults who have tested positive for islet autoantibodies, which are early markers of type 1 diabetes. Over up to 10 years, researchers will track how their blood sugar, immune system, and metabolism change. The goal is to better predi…
Matched conditions: IMPAIRED GLUCOSE TOLERANCE (PREDIABETES)
Sponsor: Società Italiana di Endocrinologia e Diabetologia Pediatrica • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC